MOLINA ARTURO MD 4

What Happened

• Arturo Molina, MD, Chief Medical Officer of Protagonist Therapeutics, sold 9,514 shares in an open-market transaction on 2026-01-20 at $82.48 per share, generating proceeds of approximately $784,715. This was a sale (routine disposition) to satisfy tax withholding obligations tied to the settlement of restricted stock units (RSUs).

Key Details

• Transaction date: 2026-01-20; Price: $82.48 per share; Shares sold: 9,514; Proceeds: ~$784,715.
• Transaction type/code: Sale (S); reported on Form 4 filed 2026-01-21.
• Footnote: F1 — Sale was to cover tax withholding arising from RSU settlement.
• Shares owned after the transaction: not disclosed in the provided filing.
• Filing timeliness: Report filed the next day (no late filing flag noted).

Context

• The sale was identified as a tax-withholding disposition tied to RSU settlement; such sales are common and typically reflect tax obligations rather than a directional bet on the stock.
• For retail investors, purchases by insiders may be more informative about sentiment than routine withholding sales like this one.